2024-01-17RELRCSBRCSBRCSB2021-11-272022-01-192022-01-192024-01-17National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)R01AI163395United StatesSubtomogram averaging of SARS-CoV-2 Spike Protein bound to CV3-1Li WMothes WComplex, Glycoprotein, VIRAL PROTEINLi WChen YPrevost JUllah ILu MGong SYTauzin AGasser RVezina DAnand SPGoyette GChaterjee DDing STolbert WDGrunst MWBo YZhang SRichard JZhou FHuang RKEsser LZeher ACote MKumar PSodroski JXia DUchil PDPazgier MFinzi AMothes WStructural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern.Cell RepUS38110210110210202234971573doi:10.1016/j.celrep.2021.1102102211-1247SARS-CoV-2 Spike protein bound to Fab CV3-1SARS-CoV-2 Spike protein bound to Fab CV3-1012Severe acute respiratory syndrome coronavirus 2subtomogramAveragingparticle7.4ETHANEFEI TITAN KRIOSOTHERBRIGHT FIELDFIELD EMISSION GUN300GATAN K3 BIOQUANTUM (6k x 4k)3.01C3FOURIER SPACE12.0FSC 0.143 CUT-OFF1226561353OTHER